Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers
Smoking is associated with an increased risk of respiratory tract infection in adults likely because components in the smoke might alter properties of the epithelial cell surface. In studies with smokers suffering from acute exacerbations of COPD (AECOPD), the most common bacterial pathogens found w...
Main Authors: | Franco Pasqua, Gianluca Biscione, Girolmina Crigna, Mario Cazzola |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2008-08-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753465808094914 |
Similar Items
-
Pharmacokinetics of Oral Prulifloxacin Capsules in Healthy Volunteers
by: Jing Zou, et al.
Published: (2011-03-01) -
Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study
by: Konstantinos Gourgoulianis, et al.
Published: (2021-01-01) -
Aging-related systemic manifestations in COPD patients and cigarette smokers.
by: Laurent Boyer, et al.
Published: (2015-01-01) -
Acute exacerbations of COPD: risk factors for failure and relapse
by: Mantero M, et al.
Published: (2017-09-01) -
Use of azithromycin in the treatment of acute exacerbations of COPD
by: Aaron P Milstone
Published: (2008-08-01)